Credit: Getty Images. The approval was based on data from 3 clinical studies that assessed the antihypertensive effect of valsartan in 290 children 1 to less than 6 years of age. The Food and Drug ...

Generic Diovan is coming. The Wall Street Journal reports that generics drugmaker Ranbaxy has scored an FDA approval to manufacture an off-brand version of the blood pressure medication. The drug will ...

Problems surrounding the blood pressure-lowering drug Diovan have shed fresh light on opaque and sometimes questionable ties between medical researchers and pharmaceutical firms. More facts behind ...

Investigations by Japanese universities found data had been manipulated in studies on Diovan, a blood-pressure drug manufactured by Swiss drug maker Novartis. The WSJ's Kana Inagaki tells Mariko ...

It now expects the long-delayed U.S. release of a generic of its blockbuster Diovan to happen in the second quarter and by summer's end hopes to have completed the strategic review that will ...

The FDA has approved Novartis’ Diovan HCT (valsartan/hydrochlorothiazide tablets) and Exforge (amlodipine/valsartan tablets) as first-line therapies for hypertension in patients likely to need ...

BASEL -- Swiss drug-maker Novartis AG Wednesday said its best-selling drug, the high-blood-pressure treatment Diovan, was well on track to soon achieve annual sales of $4 billion. At a ...

This leaflet answers some common questions about Co-Diovan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information ...